Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TREMELIMUMAB vs TREPROSTINIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TREMELIMUMAB vs TREPROSTINIL: Safety Overview

Metric TREMELIMUMAB TREPROSTINIL
Total FAERS Reports 2,387 91,795
Deaths Reported 594 8,865
Death Rate 24.9% 9.7%
Hospitalizations 1,510 35,507
Average Patient Age 64.7 yrs 58.6 yrs
% Female Patients 31.6% 73.2%
FDA Approval Date N/A Feb 11, 2021
Manufacturer AstraZeneca Pharmaceuticals LP United Therapeutics Corporation
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription